SCHEMBL28293

SCHEMBL28293

O=C(O)c1cccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31605465 1.00
SCHEMBL28279241 0.98 P2RX7 (0.57)
Hydrochloric Acid SCHEMBL11797023 0.98 P2RX7 (0.57)
SCHEMBL22288333 0.98 P2RX7 (0.57)
SCHEMBL15956532 0.98 P2RX7 (0.57)
Formaldehyde SCHEMBL27859574 0.96 P2RX7 (0.55)
Acetic Acid SCHEMBL27708374 0.94 P2RX7 (0.53)
Trifluoroacetic Acid SCHEMBL30489000 0.88 P2RX7 (0.49)
Pyrrole SCHEMBL6111844 0.88 P2RX7 (0.53)
Piperazine SCHEMBL27529829 0.88 P2RX7 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492193-B2 Pyrazole derivatives for the treatment of cystic fibrosis FONDAZIONE INSTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-12-09 US claimed
EP-4646271-A1 SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES Mirati Therapeutics, Inc. (US) 2025-11-12 EP claimed
CN-120072903-A Composite positive electrode material of fast-charging sodium-ion battery and preparation method thereof 浙江华宇钠电新能源科技有限公司 2025-05-30 CN claimed
CN-120006268-A Leadless high-phosphorus chemical nickel plating solution 珠海联鼎化工设备有限公司 2025-05-16 CN claimed
CN-110167944-B Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors 联合疗法公司 2024-08-23 CN claimed
WO-2024148150-A1 SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES Mirati Therapeutics, Inc. (US) 2024-07-11 WO claimed
EP-3551632-B1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION THERAPEUTICS AS (DK) 2024-06-12 EP claimed
CN-117510489-A Dissolved coptisine type alkaloid quaternary ammonium salt and application thereof in preparing medicines 中国医学科学院药物研究所 2024-02-06 CN claimed
CN-111295382-B Bridged bicyclic compounds as farnesyl ester X receptor modulators 百时美施贵宝公司 2024-02-02 CN claimed
CN-116554236-A Cationic rare earth doped aluminum oxide cluster compound, and macro preparation method and application thereof 闽都创新实验室 2023-08-08 CN claimed
EP-0701446-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-03-20 EP claimed
WO-1995011693-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1995-05-04 WO claimed
WO-1994027627-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-12-08 WO claimed
EP-0621788-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-11-02 EP claimed
CN-1077960-A HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1993-11-03 CN claimed
WO-1993013789-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1993-07-22 WO claimed
EP-0169144-B1 PROCESS FOR THE PREPARATION OF 7-AMINO AND 7-SUBSTITUTED AMINO-DESACETOXYCEPHALOSPORINS FROM THE CORRESPONDING 6-SUBSTITUTED AMINO PENICILLIN SULPHOXIDES GEMA S.A. (ES) 1990-06-06 EP claimed
EP-0214158-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-03-18 EP claimed
US-4623378-A HYBRIIZATION OF PLANTS CIBA-GEIGY CORPORATION (US) 1986-11-18 US claimed
WO-1986004582-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1986-08-14 WO claimed